<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>OBJECTIVE: To determine the expression and function of c-kit receptor on bone marrow mononuclear cells (BMMNC) of the patients with <z:hpo ids='HP_0002863'>myelodysplastic syndromes</z:hpo> </plain></SENT>
<SENT sid="1" pm="."><plain>METHODS: c-kit protein (CD(117)) was detected by direct immunofluorescence assay, c-kit <z:chebi fb="2" ids="33699">mRNA</z:chebi> by reverse transcriptive polymerase chain reaction (RT-PCR) and the function of c-kit receptor by cell culture </plain></SENT>
<SENT sid="2" pm="."><plain>RESULTS: c-kit protein expression in <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e> was significantly higher than that in control [(8.58 +/- 5.28)% vs (3.04 +/- 1.49)%, P &lt; 0.05] </plain></SENT>
<SENT sid="3" pm="."><plain>c-kit protein expression in RA patients was significantly lower than that in <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">RAEB</z:e>/<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">RAEB</z:e>-t patients [(5.12 +/- 2.13)% vs (10.01 +/- 5.07)%, P &lt; 0.05] </plain></SENT>
<SENT sid="4" pm="."><plain>The rate of c-kit protein expression was (32.43 +/- 18.16)% in <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">AML</z:e> cases transformed from <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e> (t-<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">AML</z:e>) </plain></SENT>
<SENT sid="5" pm="."><plain>c-kit <z:chebi fb="2" ids="33699">mRNA</z:chebi> expression in <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e> was correlated with c-kit protein expression </plain></SENT>
<SENT sid="6" pm="."><plain>Addition of interleukin-3 (IL-3), erythropoietin (Epo) and stem cell factor (SCF) to the semi-solid culture of BMMNC showed significant stimulating effects on CFU-GM and BFU-E formation in <z:mpath ids='MPATH_458'>normal</z:mpath> controls, but did not in <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e> patients </plain></SENT>
<SENT sid="7" pm="."><plain>CONCLUSION: The protein and <z:chebi fb="2" ids="33699">mRNA</z:chebi> expressions of c-kit receptor on BMMNC in <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e> are higher than those in <z:mpath ids='MPATH_458'>normal</z:mpath> control, and the function of this receptor in <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e> is abnormal </plain></SENT>
</text></document>